Client Transactions

The Harvard Drug Group

July 6, 2015 Piper Jaffray co-advises The Harvard Drug Group on $1.1 billion sale to Cardinal Health.

 

University of Texas System Board of Regents

April 1, 2014Piper Jaffray serves as co-manager for $259.1 million revenue financing system bonds.

Recent News

August 17, 2015 Former Ceridian CEO Stuart C. Harvey Jr. appointed Piper Jaffray merchant banking partner

August 6, 2015 Piper Jaffray announces share repurchase authorization